Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2.
Saved in:
| Title: | Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. |
|---|---|
| Authors: | Bräutigam, Jacqueline1 (AUTHOR), Bischoff, Iris1 (AUTHOR), Schürmann, Christoph1 (AUTHOR), Buchmann, Giulia1 (AUTHOR), Epah, Jeremy1 (AUTHOR), Fuchs, Simone1 (AUTHOR), Heiss, Elke1 (AUTHOR), Brandes, Ralf P.1 (AUTHOR), Fürst, Robert1 (AUTHOR) fuerst@em.uni-frankfurt.de |
| Source: | Journal of Molecular & Cellular Cardiology. Oct2019, Vol. 135, p97-108. 12p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
